Suppr超能文献

腺病毒介导的体内基因转移及在正常大鼠肝脏中的表达。

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.

作者信息

Jaffe H A, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld M A, Gant T W, Thorgeirsson S S, Stratford-Perricaudet L D, Perricaudet M

机构信息

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Nat Genet. 1992 Aug;1(5):372-8. doi: 10.1038/ng0892-372.

Abstract

Replication deficient, recombinant adenovirus (Ad) vectors do not require target cell replication for transfer and expression of exogenous genes and thus may be useful for in vivo gene therapy in hepatocytes. In vitro, primary cultures of rat hepatocytes infected with a recombinant Ad containing a human alpha 1-antitrypsin cDNA (Ad-alpha 1AT) synthesized and secreted human alpha 1AT for 4 weeks. In rats, in vivo intraportal administration of a recombinant Ad containing the E. coli lacZ gene, was followed by expression of beta-galactosidase in hepatocytes 3 days after infection. Intraportal infusion of Ad-alpha 1AT produced detectable serum levels of human alpha 1AT for 4 weeks. Thus, targeted gene expression has been achieved in the liver, albeit at low levels, suggesting that adenovirus vectors may be a useful means for in vivo gene therapy in liver disorders.

摘要

复制缺陷型重组腺病毒(Ad)载体在转移和表达外源基因时不需要靶细胞进行复制,因此可能对肝细胞的体内基因治疗有用。在体外,用含有人α1-抗胰蛋白酶cDNA的重组腺病毒(Ad-α1AT)感染的大鼠原代肝细胞培养物能合成并分泌人α1-抗胰蛋白酶达4周。在大鼠体内,经门静脉给予含大肠杆菌lacZ基因的重组腺病毒后,感染3天后肝细胞中出现β-半乳糖苷酶表达。经门静脉输注Ad-α1AT可使血清中人α1-抗胰蛋白酶水平在4周内保持可检测到。因此,尽管水平较低,但已在肝脏中实现了靶向基因表达,这表明腺病毒载体可能是肝脏疾病体内基因治疗的一种有用手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验